Breast screening and AI: Francesca Caumo (GISMa) explains the value of the Breast AI study in La Repubblica

Artificial Intelligence is entering the core of organized mammographic screening. In La Repubblica, within the Health special section, Dr. Francesca Caumo, Vice President of GISMa (Italian Group for Mammographic Screening), discusses the challenges and opportunities related to integrating new technologies into prevention pathways. At the center is the large prospective multicenter study, Breast AI, born…

Breast screening: partnership between the Italian Mammography Screening Group (GISMa) and Health Triage for one of the most innovative European studies on the use of Artificial Intelligence

An agreement has been signed for a clinical validation study involving 75,000 women: the goal is to strengthen the national prevention programme through “intelligent triage”, which optimises radiologists’ work and accelerates diagnoses. TURIN, 12 February 2026 – With the introduction of new guidelines on AI applied to prevention at the end of 2025, Italy strengthens…

BREAST CANCER SCREENING AND ARTIFICIAL INTELLIGENCE: A TURNING POINT IN THE ITALIAN NATIONAL INSTITUTE OF HEALTH GUIDELINES

The update of the national Guidelines on 23 December 2025 marks a turning point for cancer prevention in Italy. For the first time, the national panel, adopting the GRADE methodology, issued a conditional recommendation in favor of using an AI-based triage strategy for reading mammograms within breast cancer screening programs. Question 3: a strategic innovation…

Tomosynthesis and Artificial Intelligence: the ASSURE study shows a +21.6% increase in breast cancer detection

An analysis of over half a million women in the United States confirms that artificial intelligence, applied to tomosynthesis (3D mammography), improves cancer detection without increasing false positives. The results reinforce a key premise: to make screening more effective, it is not enough to “see more,” but to see better. This is the logic behind…

Cancer Research Horizons e Royal Surrey collaborano con Health Triage per migliorare lo screening del tumore al seno con l’AI

LONDRA e GUILDFORD, Regno Unito, e TORINO, Italia, 21/05/2025 – Cancer Research Horizons e il Royal Surrey NHS Foundation Trust hanno annunciato una collaborazione con Health Triage, una start-up italiana specializzata in intelligenza artificiale per la diagnostica medica, con l’obiettivo di migliorare lo screening del tumore al seno utilizzando i dati del database OPTIMAM Medical…

Health Triage and GISMa join forces for early detection of breast cancer

Health Triage S.r.l. and GISMa (Gruppo Italiano Screening Mammografico) have formalized a new collaboration aimed at improving mammography screening programs through the application of artificial intelligence. The aim of this collaboration is to evaluate the effects of a technology specialized in identifying negative cases in screening. Luckily, a large number of screening mammograms are negative,…

Industrial partnership with Agora Labs

In the coming years, technologies based on AI models in the 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 sector will have to be extremely convincing. Skepticism in being supported by these powerful technological tools will have to be overcome with scientific evidence. 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝗿𝗲𝘀𝘂𝗹𝘁𝘀 will be produced with rigorously conducted 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘃𝗮𝗹𝗶𝗱𝗮𝘁𝗶𝗼𝗻𝘀. 𝗗𝗮𝘁𝗮 𝗰𝗼𝗹𝗹𝗲𝗰𝘁𝗶𝗼𝗻, 𝗱𝗮𝘁𝗮 𝗾𝘂𝗮𝗹𝗶𝘁𝘆 and 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀 𝗼𝗳 𝗿𝗲𝘀𝘂𝗹𝘁𝘀 will…